Detalhe da pesquisa
1.
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas.
Hematol Oncol
; 41(3): 571-573, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35319789
2.
Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization.
Transfusion
; 50(11): 2432-46, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-20553434